Two drugs better than one? prostate cancer trial aims to shrink tumors before surgery
NCT ID NCT06627530
Summary
This study is testing whether using two hormone-blocking drugs together before prostate removal surgery works better than using just one drug for men with aggressive prostate cancer. Researchers want to see if the combination shrinks tumors more effectively, leaving less cancer behind after surgery. The trial involves 144 men who will receive either one drug, the other drug, or both for 24 weeks before their operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BP - A Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, 01323001, Brazil
-
Hospital Ophir Loyola
Belém, Pará, 66063-240, Brazil
-
Hospital São Marcos
Teresina, Piauí, 64001-280, Brazil
-
Hospital Universitário Pedro Ernesto
Rio de Janeiro, Rio de Janeiro, 20551-030, Brazil
-
Hospital de Clínicas Ijuí
Ijuí, Rio Grande do Sul, 98700-000, Brazil
-
Santa Casa de Misericórdia de Feira de Santana
Feira de Santana, Estado de Bahia, 44001-032, Brazil
Conditions
Explore the condition pages connected to this study.